Silvia Crescioli
King's College London(GB)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Cell Adhesion Molecules Research, HER2/EGFR in Cancer Research, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research
Most-Cited Works
- → Antibodies to watch in 2022(2022)331 cited
- → Antibodies to watch in 2023(2022)263 cited
- → Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma(2019)247 cited
- → Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action(2021)191 cited
- → Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)(2017)169 cited
- → Antibodies to watch in 2024(2024)159 cited
- → Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types(2018)131 cited
- → Antibodies to watch in 2025(2024)117 cited
- → BRAF inhibitors: resistance and the promise of combination treatments for melanoma(2017)112 cited
- → IgG4 Characteristics and Functions in Cancer Immunity(2016)104 cited